﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>hemophilia news stories on Newser</title><description>Read more hemophilia stories on Newser</description><link>http://www.newser.com/taggrid/1373/hemophilia.html</link><image><url>http://img1-cdn.newser.com/images/newser-black250x40.gif</url><title>hemophilia news stories on Newser</title><link>http://www.newser.com/</link></image><copyright>2012 - Newser</copyright><language>en-us</language><generator>Newser Feed Generator</generator><pubDate>Tue, 22 May 2012 14:54:30 CDT</pubDate><item><guid isPermaLink="true">http://www.newser.com/story/92589/anti-bleeding-drug-could-save-lives-in-the-er.html</guid><title>Anti-Bleeding Drug Could Save Lives in the ER</title><dc:creator>Nick McMaster</dc:creator><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=740963&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110331192857' border='0' /&gt;A drug used to slow bleeding during surgery could save the lives of scores of trauma patients if used in emergency rooms, a new study suggests. UK researchers found that the drug tranexamic acid reduced bleeding deaths among trauma patients by a sixth, HealthDay reports. As 600,000 such patients...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=740963&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110331192857" type="image/jpg" medium="image"><media:description type="plain">The drug could prevent 100,000 trauma patients from bleeding to death each year, say researchers.</media:description></media:content><link>http://www.newser.com/story/92589/anti-bleeding-drug-could-save-lives-in-the-er.html</link><pubDate>Tue, 15 Jun 2010 15:26:55 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/1580/drug-targets-hundreds-of-disorders.html</guid><title>Drug Targets Hundreds of Disorders</title><dc:creator>Peter Fearon</dc:creator><description>&lt;img src='http://img2-cdn.newser.com/getimage.aspx?mediaid=2881&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401035408' border='0' /&gt;A magic bullet that could treat cystic fibrosis, muscular dystrophy, hemophilia and more than 1,800 other genetic disorders could be available by 2009. Lee Sweeney of UPenn, leader of the team developing the drug, tells the Times of London: “It doesn’t just target one mutation that causes disease, but...</description><media:content url="http://img2-cdn.newser.com/getimage.aspx?mediaid=2881&amp;width=45&amp;height=45&amp;crop=Y&amp;updateddate=20110401035408" type="image/jpg" medium="image"><media:description type="plain">A lab officer cuts a DNA fragment under UV light from an agarose gel for DNA sequencing as part of research to determine genetic mutation in a blood cancer patient, Thursday April 19, 2007 in Singapore, which prides itself as an advanced medical treatment and research hub. The number of cancer cases in Asia is set to rise dramatically by 2020 due largely to longer life spans and changing lifestyles, threatening a health crisis as poorer countries in the region struggle to keep up. (AP Photo/Wong Maye-E) </media:description></media:content><link>http://www.newser.com/story/1580/drug-targets-hundreds-of-disorders.html</link><pubDate>Mon, 23 Apr 2007 08:42:13 CDT</pubDate></item></channel></rss>
